deepeye Medical is a medical equipment manufacturing company based in Munich, Bavaria, specializing in AI-based precision health solutions for retinal diseases.

Our mission is to empower ophthalmology by enabling additional insights into treatment data of patients suffering from retinal eye diseases. We provide an AI-based precision health platform that emulates a proven clinical method of second expert opinion for eye doctors, resulting in significantly better therapy outcomes. Our aim is to prevent 1 million additional people from blindness by 2030 by empowering ophthalmologists with AI-based optimal therapy prognosis.

deepeye's technology improves real-world vision outcomes by 3 times and doubles patient therapy persistence, supporting ophthalmologists in the planning of anti-VEGF therapy for neovascular age-related macular degeneration (nAMD) patients through our CE-marked medical device software deepeye® TPS.

Our products target ophthalmologists, clinics, hospitals, and researchers, helping enhance retinal therapy through actionable insights and AI-driven data analysis. Key offerings include deepeye® TPS, an AI assistant for therapy planning, and a flexible AI platform used in retinal therapy studies by pharmaceutical companies and medical device manufacturers.

Founded in 2021, deepeye Medical employs between 11-50 people. The company is privately held and located at Paul-Heyse-Str. 2-4, 80336 Munich, Germany.